Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov enrollment closed full pipeline small index

Skin Neoplasms: full-pipeline trial registry

A small indexed set (6 trials) with no open enrollment listed right now.

Corpus placement: #2,866 of 28,707 conditions by registered trial count.

6 US clinical trials · none currently recruiting · #2,866 of 28,707 conditions by registered trial count

Skin Neoplasms: 6 US clinical trials tracked, none currently recruiting.

Skin Neoplasms is the subject of 6 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. 2 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is US Department of Veterans Affairs, running 1 of these trials.

Enrollment posture brief

Registry condition skin-neoplasms

OPEN 0 | RECR 0% | LATE 2 | EARLY 2 | RANK #2866 | SPON 1

Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)

Acute Hypoxemic Respiratory 66.7%Abdominal Aortic Aneurysms50%Acupuncture50%Acute Lymphoblastic Leukemia50%Skin Neoplasms (this)0%
Open-enrollment share among volume-matched conditions near Skin Neoplasms

Skin Neoplasms has no open enrollment in this registry pull (6 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Skin Neoplasms on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Skin Neoplasms is recruiting below its size-band peers.

    0 of 6 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Skin Neoplasms research.

    US Department of Veterans Affairs accounts for 1 of 6 trials (16.7%). 6 distinct sponsors appear on at least one study for this condition label.

  3. Typical Skin Neoplasms enrolment sits around 726 participants.

    Median target enrolment is 726 among the 6 trials that report a genuine target (sentinel values excluded). 2 of those (33.3%) plan for fewer than 100 participants.

  4. Skin Neoplasms research is mostly interventional.

    5 interventional and 1 observational studies make up this index (83.3% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 22Phase 31Phase 41

Phase Distribution

PhaseTrial count
Phase 2 2
Phase 3 1
Phase 4 1

Named interventions

Most-linked intervention names on Skin Neoplasms records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

PAE physician activation, plus teledermoscopy (PAE +MD +TD) Behavioral
1 trials
PAE plus physician activation (PAE + MD) Behavioral
1 trials
Patient activation and education (PAE) Behavioral
1 trials
Axitinib [AG-013736] Drug
1 trials
Placebo, vehicle control Drug
1 trials
Tretinoin 0.1% cream or placebo Drug
1 trials
Intismeran autogene Biological
1 trials
5-fluorouracil Drug
1 trials

US sites by state

Facility locations filed on Skin Neoplasms trials. A trial with sites in several states counts in each.

California 4 trials
Pennsylvania 3 trials
Massachusetts 3 trials
Florida 3 trials
Tennessee 2 trials
Rhode Island 2 trials
North Carolina 2 trials
Illinois 2 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Skin Neoplasms page

6 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Skin Neoplasms condition card totals 6 registered trials; most-linked intervention PAE physician activation, plus teledermoscopy (PAE +MD +TD); top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.